Bio-key International, Inc. (NASDAQ: BKYI) reported Q2 EPS of ($0.56), $0.24 better than the analyst estimate of ($0.80). Revenue for the quarter came in at $1.92 million versus the consensus estimate of $2.2 million.

For earnings history and earnings-related data on Bio-key International, Inc. (BKYI) click here.